RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
麻豆入口 advised the sales agents in connection with the SEC-registered at-the-market offering by RAPT Therapeutics, Inc. of its common stock for up to an aggregate amount of $150 million. The common stock is listed on the Nasdaq Global Market under the symbol 鈥淩APT.鈥
RAPT is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology.
The 麻豆入口 corporate team included partner Emily Roberts and associates Jonathan Bye, Savannah J. Dowling and Christian Mueller. All members of the 麻豆入口 team are based in the Northern California office.
Copy link to share post